Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, Structure-Activity Relationship, and Mode of Action Studies of a New Generation of Acridine/Acridone-Based Antimalarials.

ACS infectious diseases·2026
Same author

MegaTrans-machine learning models for drug transporters corresponding to the FDA guidance.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Repurposing Clinical Candidates for Nipah and Hendra Viruses.

ACS infectious diseases·2026
Same author

Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study.

ACS omega·2026
Same author

Palmitoyl-protein thioesterase-1 in health and disease.

Trends in pharmacological sciences·2026
Same author

Spectroscopy-guided optimization of copper-based catalysts for low-temperature CO<sub>2</sub> recycling to CO.

Materials horizons·2026
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Aug 29, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K

Combining DELs and machine learning for toxicology prediction.

Vincent Blay1, Xiaoyu Li2, Jacob Gerlach3

  • 1Department of Microbiology and Environmental Toxicology, University of California at Santa Cruz, Santa Cruz, CA 95064, USA.

Drug Discovery Today
|September 12, 2022
PubMed
Summary
This summary is machine-generated.

DNA-encoded libraries (DELs) coupled with machine learning (ML) can predict compound interactions with off-targets. This approach enhances predictive toxicology early in drug discovery, reducing costs and identifying safety liabilities.

Keywords:
CheminformaticsDNA-encoded librariesDeep learning toxicology safety pharmacologyMachine learning

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K

Related Experiment Videos

Last Updated: Aug 29, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

2.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.3K
A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
09:01

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans

Published on: March 14, 2019

7.3K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Toxicology

Background:

  • DNA-encoded libraries (DELs) are powerful tools for identifying novel chemical matter in drug discovery.
  • The extensive experimental data generated by DELs is suitable for machine learning (ML) applications.
  • ML excels at modeling intricate relationships between chemical compounds and quantitative biological endpoints.

Purpose of the Study:

  • To explore the synergistic potential of combining DELs and ML for predictive toxicology.
  • To model compound binding to off-targets, thereby improving safety assessments.
  • To enable earlier identification of potential safety liabilities in the drug discovery pipeline.

Main Methods:

  • Utilizing data from DEL screening campaigns.
  • Developing and applying machine learning models to predict off-target binding.
  • Leveraging ML's ability to generalize predictions across large chemical spaces.

Main Results:

  • Demonstrated the feasibility of using DEL-generated data for ML-driven toxicology prediction.
  • Showcased the potential for accurate prediction of off-target interactions.
  • Highlighted the scalability and reusability of ML models across diverse drug discovery projects.

Conclusions:

  • The integration of DELs and ML offers a cost-effective strategy for early-stage predictive toxicology.
  • This combined approach can significantly improve the safety profiling of drug candidates.
  • Wider application of generalized toxicology models can accelerate drug discovery by mitigating safety risks early on.